Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

No.	薬物名（臨床試験情報から抽出）	DrugBank	KEGG DRUG	KEGG GENES	KEGG PATHWAY On map, Yellow: Drug target genes	指定難病告示番号
1	Tildrakizumab	Tildrakizumab	1件: D10400 💬	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	2件: 162, 271 💬
2	Tildrakizumab 100 mg (one 1-ml injection of 100 mg/ml	Tildrakizumab	1件: D10400 💬	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	1件: 271 💬
3	Tildrakizumab 100 mg/ml	Tildrakizumab	1件: D10400 💬	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	1件: 271 💬
4	Tildrakizumab 200 mg (two 1-ml injections of 100 mg/ml)	Tildrakizumab	1件: D10400 💬	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	1件: 271 💬
5	Tildrakizumab prefilled syringe	Tildrakizumab	1件: D10400 💬	1件: IL23A 💬	9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis	1件: 162 💬